Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors
Authors:
- Christopher A HammCHChristopher A Hamm
- Jeff W StevensJSJeff W Stevens
- Hehuang XieHXHehuang Xie
- Elio F VaninEVElio F Vanin
- Jose A MorcuendeJMJose A Morcuende
- Hakeem AbdulkawyHAHakeem Abdulkawy
- Elisabeth A SeftorESElisabeth A Seftor
- Simone T SredniSSSimone T Sredni
- Jared M BischofJBJared M Bischof
- Deli WangDWDeli Wang
- Sergey MalchenkoSMSergey Malchenko
- Maria de Fatima BonaldoMBMaria de Fatima Bonaldo
Open Access
- 1 September 2010
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 471-16
Abstract
Background Chondrosarcomas are malignant cartilage tumors that do not respond to traditional chemotherapy or radiation. The 5-year survival rate of histologic grade III chondrosarcoma is less than 30%. An animal model of chondrosarcoma has been established - namely, the Swarm Rat Chondrosarcoma (SRC) - and shown to resemble the human disease. Previous studies with this model revealed that tumor microenvironment could significantly influence chondrosarcoma malignancy. Methods To examine the effect of the microenvironment, SRC tumors were initiated at different transplantation sites. Pyrosequencing assays were utilized to assess the DNA methylation of the tumors, and SAGE libraries were constructed and sequenced to determine the gene expression profiles of the tumors. Based on the gene expression analysis, subsequent functional assays were designed to determine the relevancy of the specific genes in the development and progression of the SRC. Results The site of transplantation had a significant impact on the epigenetic and gene expression profiles of SRC tumors. Our analyses revealed that SRC tumors were hypomethylated compared to control tissue, and that tumors at each transplantation site had a unique expression profile. Subsequent functional analysis of differentially expressed genes, albeit preliminary, provided some insight into the role that thymosin-β4, c-fos, and CTGF may play in chondrosarcoma development and progression. Conclusion This report describes the first global molecular characterization of the SRC model, and it demonstrates that the tumor microenvironment can induce epigenetic alterations and changes in gene expression in the SRC tumors. We documented changes in gene expression that accompany changes in tumor phenotype, and these gene expression changes provide insight into the pathways that may play a role in the development and progression of chondrosarcoma. Furthermore, specific functional analysis indicates that thymosin-β4 may have a role in chondrosarcoma metastasis.Keywords
This publication has 66 references indexed in Scilit:
- Conditional Overexpression of Connective Tissue Growth Factor Disrupts Postnatal Lung DevelopmentAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Global Demethylation of Rat Chondrosarcoma Cells after Treatment with 5-Aza-2′-Deoxycytidine Results in Increased TumorigenicityPLOS ONE, 2009
- Increased CCN2 Transcription in Keloid Fibroblasts Requires Cooperativity Between AP-1 and SMAD Binding SitesAnnals of Surgery, 2007
- CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin α5β1FEBS Letters, 2006
- Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3′-untranslated region interacting with a cellular protein in human chondrosarcoma cellsOncogene, 2005
- Causes and consequences of DNA hypomethylation in human cancerBiochemistry and Cell Biology, 2005
- Role of Thymosin 4 in Tumor Metastasis and AngiogenesisJNCI: Journal of the National Cancer Institute, 2003
- Expression of collagenase-3 (MMP-13) in c-Fos-induced osteosarcomas and chondrosarcomas is restricted to a subset of cells of the osteo-/chondrogenic lineageDifferentiation, 2001
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Bone marrow endothelial cells secrete thymosin β4 and AcSDKPExperimental Hematology, 2001